ID   AGRP_HUMAN              Reviewed;         132 AA.
AC   O00253; O15459; Q2TBD9;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1997, sequence version 1.
DT   16-OCT-2019, entry version 163.
DE   RecName: Full=Agouti-related protein;
DE   Flags: Precursor;
GN   Name=AGRP; Synonyms=AGRT, ART;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9119224; DOI=10.1101/gad.11.5.593;
RA   Shutter J.R., Graham M., Kinsey A.C., Scully S., Luethy R.,
RA   Stark K.L.;
RT   "Hypothalamic expression of ART, a novel gene related to agouti, is
RT   up-regulated in obese and diabetic mutant mice.";
RL   Genes Dev. 11:593-602(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Adrenal gland;
RX   PubMed=9311920; DOI=10.1126/science.278.5335.135;
RA   Ollmann M.M., Wilson B.D., Yang Y.K., Kerns J.A., Chen Y., Gantz I.,
RA   Barsh G.S.;
RT   "Antagonism of central melanocortin receptors in vitro and in vivo by
RT   agouti-related protein.";
RL   Science 278:135-138(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT THR-67.
RX   PubMed=11602360; DOI=10.1016/s0378-1119(01)00705-3;
RA   Brown A.M., Mayfield D.K., Volaufova J., Argyropoulos G.;
RT   "The gene structure and minimal promoter of the human agouti related
RT   protein.";
RL   Gene 277:231-238(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11326303; DOI=10.1038/sj.mp.4000854;
RA   Vink T., Hinney A., van Elburg A.A., van Goozen S.H., Sandkuijl L.A.,
RA   Sinke R.J., Herpertz-Dahlmann B.M., Hebebrand J., Remschmidt H.,
RA   van Engeland H., Adan R.A.;
RT   "Association between an agouti-related protein gene polymorphism and
RT   anorexia nervosa.";
RL   Mol. Psychiatry 6:325-328(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   SeattleSNPs variation discovery resource;
RL   Submitted (JAN-2006) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   DISULFIDE BONDS.
RX   PubMed=9724530; DOI=10.1021/bi981082v;
RA   Bures E.J., Hui J.O., Young Y., Chow D.T., Katta V., Rohde M.F.,
RA   Zeni L., Rosenfeld R.D., Stark K.L., Haniu M.;
RT   "Determination of disulfide structure in agouti-related protein (AGRP)
RT   by stepwise reduction and alkylation.";
RL   Biochemistry 37:12172-12177(1998).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH MC3R; MC4R AND MC5R.
RX   PubMed=9892020; DOI=10.1210/mend.13.1.0223;
RA   Yang Y.K., Thompson D.A., Dickinson C.J., Wilken J., Barsh G.S.,
RA   Kent S.B., Gantz I.;
RT   "Characterization of Agouti-related protein binding to melanocortin
RT   receptors.";
RL   Mol. Endocrinol. 13:148-155(1999).
RN   [9]
RP   FUNCTION AS INVERSE AGONIST FOR MC3R AND MC4R.
RX   PubMed=11145747; DOI=10.1210/mend.15.1.0578;
RA   Nijenhuis W.A., Oosterom J., Adan R.A.;
RT   "AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4
RT   receptor.";
RL   Mol. Endocrinol. 15:164-171(2001).
RN   [10]
RP   IDENTIFICATION OF MATURE N-TERMINUS.
RX   PubMed=17185225; DOI=10.1016/j.chembiol.2006.10.006;
RA   Jackson P.J., Douglas N.R., Chai B., Binkley J., Sidow A., Barsh G.S.,
RA   Millhauser G.L.;
RT   "Structural and molecular evolutionary analysis of Agouti and Agouti-
RT   related proteins.";
RL   Chem. Biol. 13:1297-1305(2006).
RN   [11]
RP   IDENTIFICATION OF MATURE N-TERMINUS, CLEAVAGE BY PCSK1, AND
RP   MUTAGENESIS OF 79-ARG--ARG-82; 85-ARG-ARG-86 AND 86-ARG--ARG-89.
RX   PubMed=16384863; DOI=10.1210/en.2005-1373;
RA   Creemers J.W., Pritchard L.E., Gyte A., Le Rouzic P., Meulemans S.,
RA   Wardlaw S.L., Zhu X., Steiner D.F., Davies N., Armstrong D.,
RA   Lawrence C.B., Luckman S.M., Schmitz C.A., Davies R.A., Brennand J.C.,
RA   White A.;
RT   "Agouti-related protein is posttranslationally cleaved by proprotein
RT   convertase 1 to generate agouti-related protein (AGRP)83-132:
RT   interaction between AGRP83-132 and melanocortin receptors cannot be
RT   influenced by syndecan-3.";
RL   Endocrinology 147:1621-1631(2006).
RN   [12]
RP   FUNCTION IN MC3R AND MC4R ENDOCYTOSIS.
RX   PubMed=17041250; DOI=10.1074/jbc.m605982200;
RA   Breit A., Wolff K., Kalwa H., Jarry H., Buch T., Gudermann T.;
RT   "The natural inverse agonist agouti-related protein induces arrestin-
RT   mediated endocytosis of melanocortin-3 and -4 receptors.";
RL   J. Biol. Chem. 281:37447-37456(2006).
RN   [13]
RP   STRUCTURE BY NMR OF 87-132, FUNCTION, CIRCULAR DICHROISM, DISULFIDE
RP   BONDS, AND MUTAGENESIS OF ARG-111.
RX   PubMed=10371151; DOI=10.1016/s0014-5793(99)00553-0;
RA   Bolin K.A., Anderson D.J., Trulson J.A., Thompson D.A., Wilken J.,
RA   Kent S.B.H., Gantz I., Millhauser G.L.;
RT   "NMR structure of a minimized human agouti related protein prepared by
RT   total chemical synthesis.";
RL   FEBS Lett. 451:125-131(1999).
RN   [14]
RP   STRUCTURE BY NMR OF 87-132, DOMAIN, AND DISULFIDE BONDS.
RX   PubMed=11747427; DOI=10.1021/bi0117192;
RA   McNulty J.C., Thompson D.A., Bolin K.A., Wilken J., Barsh G.S.,
RA   Millhauser G.L.;
RT   "High-resolution NMR structure of the chemically-synthesized
RT   melanocortin receptor binding domain AGRP(87-132) of the agouti-
RT   related protein.";
RL   Biochemistry 40:15520-15527(2001).
RN   [15]
RP   STRUCTURE BY NMR OF 87-120.
RX   PubMed=12056887; DOI=10.1021/bi012000x;
RA   Jackson P.J., McNulty J.C., Yang Y.K., Thompson D.A., Chai B.,
RA   Gantz I., Barsh G.S., Millhauser G.L.;
RT   "Design, pharmacology, and NMR structure of a minimized cystine knot
RT   with agouti-related protein activity.";
RL   Biochemistry 41:7565-7572(2002).
RN   [16]
RP   VARIANT THR-67, AND POSSIBLE ASSOCIATION WITH OBESITY.
RX   PubMed=12213871; DOI=10.1210/jc.2002-011834;
RA   Argyropoulos G., Rankinen T., Neufeld D.R., Rice T., Province M.A.,
RA   Leon A.S., Skinner J.S., Wilmore J.H., Rao D.C., Bouchard C.;
RT   "A polymorphism in the human agouti-related protein is associated with
RT   late-onset obesity.";
RL   J. Clin. Endocrinol. Metab. 87:4198-4202(2002).
RN   [17]
RP   CHARACTERIZATION OF VARIANT THR-67, SUBCELLULAR LOCATION, AND
RP   FUNCTION.
RX   PubMed=15927146; DOI=10.1016/j.bcp.2005.04.033;
RA   de Rijke C.E., Jackson P.J., Garner K.M., van Rozen R.J.,
RA   Douglas N.R., Kas M.J., Millhauser G.L., Adan R.A.;
RT   "Functional analysis of the Ala67Thr polymorphism in agouti related
RT   protein associated with anorexia nervosa and leanness.";
RL   Biochem. Pharmacol. 70:308-316(2005).
CC   -!- FUNCTION: Plays a role in weight homeostasis. Involved in the
CC       control of feeding behavior through the central melanocortin
CC       system. Acts as alpha melanocyte-stimulating hormone antagonist by
CC       inhibiting cAMP production mediated by stimulation of melanocortin
CC       receptors within the hypothalamus and adrenal gland. Has very low
CC       activity with MC5R (By similarity). Is an inverse agonist for MC3R
CC       and MC4R being able to suppress their constitutive activity. It
CC       promotes MC3R and MC4R endocytosis in an arrestin-dependent
CC       manner. {ECO:0000250, ECO:0000269|PubMed:10371151,
CC       ECO:0000269|PubMed:11145747, ECO:0000269|PubMed:15927146,
CC       ECO:0000269|PubMed:17041250, ECO:0000269|PubMed:9892020}.
CC   -!- SUBUNIT: Interacts with melanocortin receptors MC3R, MC4R and
CC       MC5R. {ECO:0000269|PubMed:9892020}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:15927146}.
CC       Golgi apparatus lumen {ECO:0000269|PubMed:15927146}.
CC   -!- TISSUE SPECIFICITY: Expressed primarily in the adrenal gland,
CC       subthalamic nucleus, and hypothalamus, with a lower level of
CC       expression occurring in testis, lung, and kidney.
CC   -!- DOMAIN: The presence of a 'disulfide through disulfide knot'
CC       structurally defines this protein as a knottin.
CC       {ECO:0000269|PubMed:11747427}.
CC   -!- DISEASE: Obesity (OBESITY) [MIM:601665]: A condition characterized
CC       by an increase of body weight beyond the limitation of skeletal
CC       and physical requirements, as the result of excessive accumulation
CC       of body fat. Note=Disease susceptibility is associated with
CC       variations affecting the gene represented in this entry.
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/agrp/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; U88063; AAB52240.1; -; mRNA.
DR   EMBL; U89485; AAB68621.1; -; mRNA.
DR   EMBL; AF314194; AAL09457.1; -; Genomic_DNA.
DR   EMBL; AF281309; AAK96256.1; -; Genomic_DNA.
DR   EMBL; DQ374394; ABC88473.1; -; Genomic_DNA.
DR   EMBL; BC110443; AAI10444.1; -; mRNA.
DR   CCDS; CCDS10839.1; -.
DR   RefSeq; NP_001129.1; NM_001138.1.
DR   PDB; 1HYK; NMR; -; A=87-132.
DR   PDB; 1MR0; NMR; -; A=87-120.
DR   PDB; 2IQV; Model; -; B=87-132.
DR   PDBsum; 1HYK; -.
DR   PDBsum; 1MR0; -.
DR   PDBsum; 2IQV; -.
DR   SMR; O00253; -.
DR   BioGrid; 106688; 9.
DR   IntAct; O00253; 8.
DR   STRING; 9606.ENSP00000290953; -.
DR   BioMuta; AGRP; -.
DR   MassIVE; O00253; -.
DR   PaxDb; O00253; -.
DR   PeptideAtlas; O00253; -.
DR   PRIDE; O00253; -.
DR   ProteomicsDB; 47806; -.
DR   Ensembl; ENST00000290953; ENSP00000290953; ENSG00000159723.
DR   GeneID; 181; -.
DR   KEGG; hsa:181; -.
DR   UCSC; uc002etg.1; human.
DR   CTD; 181; -.
DR   DisGeNET; 181; -.
DR   GeneCards; AGRP; -.
DR   HGNC; HGNC:330; AGRP.
DR   HPA; HPA041017; -.
DR   MalaCards; AGRP; -.
DR   MIM; 601665; phenotype.
DR   MIM; 602311; gene.
DR   neXtProt; NX_O00253; -.
DR   OpenTargets; ENSG00000159723; -.
DR   PharmGKB; PA24627; -.
DR   eggNOG; ENOG410J14P; Eukaryota.
DR   eggNOG; ENOG410Z66T; LUCA.
DR   GeneTree; ENSGT00940000154258; -.
DR   HOGENOM; HOG000033861; -.
DR   InParanoid; O00253; -.
DR   KO; K05231; -.
DR   OMA; TNPCSRT; -.
DR   OrthoDB; 1404700at2759; -.
DR   PhylomeDB; O00253; -.
DR   TreeFam; TF330729; -.
DR   Reactome; R-HSA-9615017; FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes.
DR   SIGNOR; O00253; -.
DR   EvolutionaryTrace; O00253; -.
DR   GeneWiki; Agouti-related_peptide; -.
DR   GenomeRNAi; 181; -.
DR   Pharos; O00253; -.
DR   PRO; PR:O00253; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000159723; Expressed in 66 organ(s), highest expression level in left adrenal gland.
DR   ExpressionAtlas; O00253; baseline and differential.
DR   Genevisible; O00253; HS.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0005796; C:Golgi lumen; IDA:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005184; F:neuropeptide hormone activity; IDA:UniProtKB.
DR   GO; GO:0005102; F:signaling receptor binding; TAS:ProtInc.
DR   GO; GO:0008343; P:adult feeding behavior; IEA:Ensembl.
DR   GO; GO:0007623; P:circadian rhythm; IEA:Ensembl.
DR   GO; GO:0042755; P:eating behavior; IEA:Ensembl.
DR   GO; GO:0007631; P:feeding behavior; TAS:ProtInc.
DR   GO; GO:0009755; P:hormone-mediated signaling pathway; IEA:InterPro.
DR   GO; GO:0048571; P:long-day photoperiodism; IEA:Ensembl.
DR   GO; GO:0060135; P:maternal process involved in female pregnancy; IEA:Ensembl.
DR   GO; GO:0007218; P:neuropeptide signaling pathway; IDA:UniProtKB.
DR   GO; GO:2000253; P:positive regulation of feeding behavior; IEA:Ensembl.
DR   GO; GO:0060259; P:regulation of feeding behavior; IDA:UniProtKB.
DR   GO; GO:0032868; P:response to insulin; IEA:Ensembl.
DR   Gene3D; 4.10.760.10; -; 1.
DR   InterPro; IPR007733; Agouti.
DR   InterPro; IPR027300; Agouti_dom.
DR   InterPro; IPR036836; Agouti_dom_sf.
DR   PANTHER; PTHR16551; PTHR16551; 1.
DR   Pfam; PF05039; Agouti; 1.
DR   SMART; SM00792; Agouti; 1.
DR   SUPFAM; SSF57055; SSF57055; 1.
DR   PROSITE; PS60024; AGOUTI_1; 1.
DR   PROSITE; PS51150; AGOUTI_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Disease mutation; Disulfide bond;
KW   Golgi apparatus; Knottin; Obesity; Reference proteome; Secreted;
KW   Signal.
FT   SIGNAL        1     20       {ECO:0000255}.
FT   PROPEP       21     82       {ECO:0000269|PubMed:16384863,
FT                                ECO:0000269|PubMed:17185225}.
FT                                /FTId=PRO_0000434044.
FT   CHAIN        83    132       Agouti-related protein.
FT                                /FTId=PRO_0000001034.
FT   DOMAIN       87    129       Agouti. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00494}.
FT   REGION      111    113       Interaction with melanocortin receptors.
FT   SITE         82     83       Cleavage; by PCSK1.
FT                                {ECO:0000269|PubMed:16384863}.
FT   DISULFID     87    102       {ECO:0000269|PubMed:10371151,
FT                                ECO:0000269|PubMed:11747427,
FT                                ECO:0000269|PubMed:9724530}.
FT   DISULFID     94    108       {ECO:0000269|PubMed:10371151,
FT                                ECO:0000269|PubMed:11747427,
FT                                ECO:0000269|PubMed:9724530}.
FT   DISULFID    101    119       {ECO:0000269|PubMed:10371151,
FT                                ECO:0000269|PubMed:11747427,
FT                                ECO:0000269|PubMed:9724530}.
FT   DISULFID    105    129       {ECO:0000269|PubMed:10371151,
FT                                ECO:0000269|PubMed:11747427,
FT                                ECO:0000269|PubMed:9724530}.
FT   DISULFID    110    117       {ECO:0000269|PubMed:10371151,
FT                                ECO:0000269|PubMed:11747427,
FT                                ECO:0000269|PubMed:9724530}.
FT   VARIANT      67     67       A -> T (polymorphism that may play a role
FT                                in obesity in an age-dependent manner;
FT                                apparently no effect on activity;
FT                                dbSNP:rs5030980).
FT                                {ECO:0000269|PubMed:11602360,
FT                                ECO:0000269|PubMed:12213871,
FT                                ECO:0000269|PubMed:15927146}.
FT                                /FTId=VAR_015385.
FT   MUTAGEN      79     82       REPR->AEPA: Cleavage is blocked.
FT                                {ECO:0000269|PubMed:16384863}.
FT   MUTAGEN      85     86       RR->AA: No effect on cleavage.
FT                                {ECO:0000269|PubMed:16384863}.
FT   MUTAGEN      86     89       RCVR->ACVA: No effect on cleavage.
FT                                {ECO:0000269|PubMed:16384863}.
FT   MUTAGEN     111    111       R->A: Abolishes inhibition of cAMP
FT                                production in response to melanocortin
FT                                receptor stimulation.
FT                                {ECO:0000269|PubMed:10371151}.
FT   CONFLICT      6      6       V -> L (in Ref. 2; AAB68621).
FT                                {ECO:0000305}.
FT   STRAND       95     97       {ECO:0000244|PDB:1HYK}.
FT   STRAND      101    103       {ECO:0000244|PDB:1HYK}.
FT   STRAND      107    115       {ECO:0000244|PDB:1HYK}.
FT   STRAND      117    120       {ECO:0000244|PDB:1HYK}.
FT   STRAND      125    127       {ECO:0000244|PDB:1HYK}.
SQ   SEQUENCE   132 AA;  14440 MW;  1CCBE112C3EB10F5 CRC64;
     MLTAAVLSCA LLLALPATRG AQMGLAPMEG IRRPDQALLP ELPGLGLRAP LKKTTAEQAE
     EDLLQEAQAL AEVLDLQDRE PRSSRRCVRL HESCLGQQVP CCDPCATCYC RFFNAFCYCR
     KLGTAMNPCS RT
//